Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative disorders: a large-scale propensity-matched cohort study
Excretion Pathways Elimination of GLP2 occurs through multiple routes: Primary excretion via urine (approximately 66% of administered radioactivity in human ADME studies) Secondary elimination in feces (approximately 33% of dose) Intact GLP2 not detected in urine or feces
Macronutrient balanced : Ensures consistent daily intake
Specifically, Skovronsky noted a goal to deliver efficacy similar to injectable GLP-1 monotherapy in an easy-to-use daily pill. Skovronsky added that we expect results from up to six phase III studies by the end of 2026, and expect retatrutide can deliver deeper and more rapid weight-loss than existing obesity medicines, even more than tirzepatide, the prescription drug sold under brand names such as Mounjaro and Zepbound
It can meaningfully amplify how well it works
GLP-1 RAs improve glycemic control, promote cardiovascular and renal protection, and reduce all-cause mortality [2, 3]